These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4902185)

  • 41. Pimozide versus chlordiazepoxide in anxiety neurosis.
    Doongaji DR; Sheth AS; Apte JS; Bharucha MP; Mundra VM; Ramesh S
    Acta Psychiatr Belg; 1981; 81(4):416-23. PubMed ID: 7036658
    [No Abstract]   [Full Text] [Related]  

  • 42. Combined therapy in anxiety-depressive syndromes. I. Comparative effects of limbitrol (chlordiazepoxide-amitriptyline) and placebo.
    Houck JE
    Dis Nerv Syst; 1970 Apr; 31(4):269-73. PubMed ID: 4912218
    [No Abstract]   [Full Text] [Related]  

  • 43. Depressive illness, pulse rate and forearm blood flow.
    Noble P; Lader M
    Br J Psychiatry; 1971 Sep; 119(550):261-6. PubMed ID: 5568194
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
    [No Abstract]   [Full Text] [Related]  

  • 46. Loxapine in neurotic anxiety: some modifiers of treatment response.
    Rickels K; Weise CC; Feldman H; Fee EA; Wiswesser G
    J Int Med Res; 1978; 6(3):180-5. PubMed ID: 348533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of hydroxyzine (Vistaril) in the treatment of anxiety neurosis.
    Goldberg HL; Finnerty RJ
    Psychosomatics; 1973; 14(1):38-41. PubMed ID: 4605357
    [No Abstract]   [Full Text] [Related]  

  • 49. Somatic manifestations in women with generalized anxiety disorder. Psychophysiological responses to psychological stress.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1113-9. PubMed ID: 2589925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

  • 51. Implementation of psychotherapy by librium in a pioneering rural-industrial psychiatric practice.
    Podobnikar IG
    Psychosomatics; 1971; 12(3):205-9. PubMed ID: 4950860
    [No Abstract]   [Full Text] [Related]  

  • 52. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB; Free SM
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract]   [Full Text] [Related]  

  • 53. A controlled replication of the effectiveness of diphenylhydantoin in reducing irritability and anxiety in selected neurotic outpatients.
    Stephens JH; Shaffer JW
    J Clin Pharmacol; 1973; 13(8):351-6. PubMed ID: 4579971
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of severe anxiety in outpatients: a controlled study comparing chlordiazepoxide and chlorpromazine.
    Yamamoto J; Kline FM; Burgoyne RW
    Psychosomatics; 1973; 14(1):46-51. PubMed ID: 4605352
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of self-rating scales in a single-patient multiple cross-over trial.
    Kellner R; Sheffield BF
    Br J Psychiatry; 1968 Feb; 114(507):193-6. PubMed ID: 4867804
    [No Abstract]   [Full Text] [Related]  

  • 56. Paradoxical influence of a therapeutic side-effect interpretation.
    Lipman RS; Park LC; Rickels K
    Arch Gen Psychiatry; 1966 Nov; 15(5):462-74. PubMed ID: 5332823
    [No Abstract]   [Full Text] [Related]  

  • 57. Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
    Cooper AJ; Magnus RV; Rose M; Phanjoo A; Lancaster NP; Pollard P; Knowlson P
    Br J Psychiatry; 1973 Oct; 123(575):475-6. PubMed ID: 4584032
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential drug effects in neurotic depression.
    Rickels K; Hesbacher P; Downing RW
    Dis Nerv Syst; 1970 Jul; 31(7):468-75. PubMed ID: 4918448
    [No Abstract]   [Full Text] [Related]  

  • 59. 1. Improvement criteria in drug trials with neurotic patients.
    Kellner R
    Psychol Med; 1971 Nov; 1(5):416-25. PubMed ID: 4945831
    [No Abstract]   [Full Text] [Related]  

  • 60. Phenaglycodol in anxiety: a controlled study.
    Rickels K; Csanalosi I; Gratch M; Gingrich RL; Kelly EA; Mirman MJ
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):23-31. PubMed ID: 806427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.